Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Carroll

Showing results (501-510 of 573) with videos related to

Pageof 58
Sort By:
Journal of the Canadian Association of Gastroenterology|July 12, 2019
The Impact of Inflammatory Bowel Disease in Canada 2018: A Scientific Report from the Canadian Gastro-Intestinal Epidemiology Consortium to Crohn's and Colitis CanadaEric I Benchimol, Charles N Bernstein, Alain Bitton, et al.
Vaccine|July 13, 2021
One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge modelKaren E Gooch, Trevor R F Smith, Francisco J Salguero, et al.
Msphere|September 2, 2017
Deep Sequencing of RNA from Blood and Oral Swab Samples Reveals the Presence of Nucleic Acid from a Number of Pathogens in Patients with Acute Ebola Virus Disease and Is Consistent with Bacterial Translocation across the GutMiles W Carroll, Sam Haldenby, Natasha Y Rickett, et al.
Nature Communications|August 23, 2020
A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interactionMonir Ejemel, Qi Li, Shurong Hou, et al.
Genome Biology|January 20, 2017
Transcriptomic signatures differentiate survival from fatal outcomes in humans infected with Ebola virusXuan Liu, Emily Speranza, César Muñoz-Fontela, et al.
Gastroenterology|January 15, 2019
Past and Future Burden of Inflammatory Bowel Diseases Based on Modeling of Population-Based DataStephanie Coward, Fiona Clement, Eric I Benchimol, et al.
Antimicrobial Agents and Chemotherapy|June 5, 2013
Efficacy and safety of metronidazole for pulmonary multidrug-resistant tuberculosisMatthew W Carroll, Doosoo Jeon, James M Mountz, et al.
Ebiomedicine|December 6, 2020
Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret modelPamela C Proud, Daphne Tsitoura, Robert J Watson, et al.
The American Journal of Gastroenterology|February 1, 2024
Forecasting the Incidence and Prevalence of Inflammatory Bowel Disease: A Canadian Nationwide AnalysisStephanie Coward, Eric I Benchimol, Charles N Bernstein, et al.
Msphere|July 21, 2021
Amplicon and Metagenomic Analysis of Middle East Respiratory Syndrome (MERS) Coronavirus and the Microbiome in Patients with Severe MERSWaleed Aljabr, Muhannad Alruwaili, Rebekah Penrice-Randal, et al.
Pageof 58

Showing results (501-510 of 573) with videos related to

Sort By:
Pageof 58
Journal of the Canadian Association of Gastroenterology|July 12, 2019
The Impact of Inflammatory Bowel Disease in Canada 2018: A Scientific Report from the Canadian Gastro-Intestinal Epidemiology Consortium to Crohn's and Colitis CanadaEric I Benchimol, Charles N Bernstein, Alain Bitton, et al.
Vaccine|July 13, 2021
One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge modelKaren E Gooch, Trevor R F Smith, Francisco J Salguero, et al.
Msphere|September 2, 2017
Deep Sequencing of RNA from Blood and Oral Swab Samples Reveals the Presence of Nucleic Acid from a Number of Pathogens in Patients with Acute Ebola Virus Disease and Is Consistent with Bacterial Translocation across the GutMiles W Carroll, Sam Haldenby, Natasha Y Rickett, et al.
Nature Communications|August 23, 2020
A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interactionMonir Ejemel, Qi Li, Shurong Hou, et al.
Genome Biology|January 20, 2017
Transcriptomic signatures differentiate survival from fatal outcomes in humans infected with Ebola virusXuan Liu, Emily Speranza, César Muñoz-Fontela, et al.
Gastroenterology|January 15, 2019
Past and Future Burden of Inflammatory Bowel Diseases Based on Modeling of Population-Based DataStephanie Coward, Fiona Clement, Eric I Benchimol, et al.
Antimicrobial Agents and Chemotherapy|June 5, 2013
Efficacy and safety of metronidazole for pulmonary multidrug-resistant tuberculosisMatthew W Carroll, Doosoo Jeon, James M Mountz, et al.
Ebiomedicine|December 6, 2020
Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret modelPamela C Proud, Daphne Tsitoura, Robert J Watson, et al.
The American Journal of Gastroenterology|February 1, 2024
Forecasting the Incidence and Prevalence of Inflammatory Bowel Disease: A Canadian Nationwide AnalysisStephanie Coward, Eric I Benchimol, Charles N Bernstein, et al.
Msphere|July 21, 2021
Amplicon and Metagenomic Analysis of Middle East Respiratory Syndrome (MERS) Coronavirus and the Microbiome in Patients with Severe MERSWaleed Aljabr, Muhannad Alruwaili, Rebekah Penrice-Randal, et al.
Pageof 58